o( Phenyl cx piperidyl acetic acid methyl ester hydrochloride (methyl phenidate, "ritalin ") has recently been introduced as a central nervous system stimulant. Animal experiments have shown that it increases psychomotor activity and has a pressor effect. Its effectiveness in counteracting the effects of hypnotics in man, experimentally and in cases of poisoning, has been reported, as has its usefulness in treating reserpine-induced depression. It has also been used in other depressive states where its action was considered to be beneficial in reducing the disorder of mood and in increasing confidence and speed of activity (Meier, Gross, and Tripod, 1954; Heiss, Becker, Hiltman, and Honsberg, 1956; Ferguson, 1955; Geller, 1955; Stier, 1955) . None of these conducting clinical reports so far has utilized controls, and this paper describes a " blind " trial in which, in addition to general out-patient management and supervision, two comparable groups of depressed patients were given either the drug or a placebo over a period of four weeks.
Selection of Cases
All the patients treated were suffering from mild or moderately severe depressive reactions. Cases were selected by the following criteria: (a) Complaint of depression as a prominent symptom; (b) evidence of depression at interview, e.g. sad, careworn expression, general bearing, and lack of spontaneity.
In addition, all patients showed four or more of the following abnormalities: (a) Sleep disturbance; (b) loss of appetite and weight; (c) impairment of interests; (d) lack of confidence; (e) reduced alertness; (f) retardation or agitation.
Care was taken to exclude from the group cases where the anxiety component was sufficiently large to contraindicate stimulant medication or where symptoms of a physical nature were prominent.
Method Sealed envelopes were prepared containing the prescription of placebo or methyl phenidate (10 mg. tablets) and were thoroughly shuffled. The placebo tablets were identical in appearance with the active tablets. The psychiatrist and patient were thus unaware of the true nature of the tablets the patient received during the course of the trial.
Each patient was examined at an initial interview and the actuarial data, diagnosis, prognosis rating, etc., and the results of the modified Minnesota multiphasic personality inventory (M.M.P.I.) (Hathaway and McKinley, 1951) , the Kent oral intelligence test (Kent, 1946) , and an adapted Porteus maze test (Porteus, 1952) recorded. The initial prescription of 1 tablet b.d. was then given.
The patient was seen again after a maximum period of a fortnight and the dose of tablets raised from 1 b.d. to 2 b.d. if improvement was not evident.
The patient was seen a third time after four weeks and after neutral conversation the psychiatrist entered his rating of the results of treatment. The patient was then asked to rate his own improvement and was finally retested with the M.M.P.I. and the Porteus maze test.
Group Matching.-Forty-five cases were treated in all. Of the 23 control patients, none failed to complete treatment. Of the 22 drug-treated cases, two failed to return. Observed, therefore, over one month were 23 control patients and 20 drug-treated patients.
The groups corresponded closely in their sex distribution, age, civil state, personality type, precipitating factor, duration of illness, type of treatment given previously and concurrently, intelligence as measured by the Kent oral test, prognosis as estimated by the psychiatrist, and depth of depression as measured by the version of the M.M.P.I. devised by the authors (Table I) .
The personality type was defined as obsessive or hysteroid according to which characteristics predominated. Obsessive characteristics were excessive cleanliness, orderliness, conscientiousness, vacillation, submissiveness, and lack of confidence. Hysteroid characteristics were over-demonstrativeness, impulsiveness, changeability, exhibitionism, and a tendency to vivid phantasy.
The prognosis rating was, after Davies and Shepherd (1955) attracted by a magnet ? " to " Give me the four large cities " or " Name some birds". scores of the four sub-tests (1, 3, 4, and 5) ar two combinations (1, 3, and 4, and 1, 4, and 5 a scale the mental age may be derived. 70 (mean score 53-3 ± 7-7), while of 45 patients, 39 scored over 70 (mean score 84-1 ± 14-3) (t = 6-71; P = < 001). Five patients later rated as "much improved " had a mean score of 60-0 7 7, 18 as " improved" had a mean score of 73-7 i 15-6, and 17 as " not improved " a mean score of 81-5 12-7.
(Comparing " much improved " and " improved " t = 1-83, P > 0-05; comparing " improved " and " not improved " t = 1-12, P = 0 3; comparing " much improved " and "not improved " t = 3 35, P = < 0-01).
To show whether the drug had any demonstrable effect on speed of performance, a set of Porteus mazes was used with the alternative paths blocked so that the subject merely had to trace a line as quickly as possible, avoiding the sides of the maze.
Results of Treatment
The results of treatment were assessed by (1) a n rating scale administered by the psychiatrist; (2) month of treatment. Two of these three cases 0-34 P -0-2 abandoned the drug because of ill-effects, primarily increased tension, one because she felt no effects from the tablets and thought them superfluous.
The results in the 40 patients who completed treatment are shown in Table II. The results of the psychiatrists' ratings were added to give a sum in each case. These sums were a names of written out in rank order and the median obtained.
The raw The number of methyl phenidate-treated cases and re added in placebo-treated cases scoring more than and less 5) and from than the median is given in Table II . Those scoring more than the median were assessed as "good Sal estimate results" and those less than the median as "poor between the first and second maze performance was atement of expressed as a percentage of the first performance ny health , and finally also dealt with as above, being classified inot under-as " speeded up " or " not speeded up or slower" 
